Xambo, 80 boxes of bulk capsules. Each containing 12,053 capsules in each box.

FDA recall notice · announced February 8, 2017 · West Coast Laboratories

Class II FDA/FSIS Class II: use may cause temporary or medically reversible adverse health consequences.

The product

Xambo, 80 boxes of bulk capsules. Each containing 12,053 capsules in each box.

Reason for recall

West Coast Laboratories is recalling Xambo and Devagrass because there may be presence of 1,3-dimethylamylamine (DMAA).

Notes

Distribution: Colombia, South America
Lot/code information: 361215
Quantity: 964,240 capsules
Status: Terminated
Products in this recall event:
- Devagrass (F-1431-2017)
- Xambo, 80 boxes of bulk capsules. Each containing 12,053 capsules in each box. (F-1430-2017)

Source: U.S. Food and Drug Administration public recall data. This page reports official records and is not legal, medical, or repair advice.